Regional
Region One Metropolitan Ambulance Council (MAC)
Region One Metropolitan Ambulance Council (MAC) (New Orleans, LA) carries 39 drugs across 143 dose entries in its current published protocol, effective 2024-03-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses39
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6–12 mg | IV/IO | not captured | standing | page 224 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 224 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 224 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 225 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 225 |
| Other | adult | 5 mg | NEB | not captured | standing | page 225 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-ROSC care | adult | 150 mg | IV/IO | not captured | standing | page 226 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 226 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 226 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 226 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 160–325 mg | PO | not captured | standing | page 228 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 229 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 229 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 229 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 8–16 mg | PO | not captured | standing | page 230 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | standing | page 231 |
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 231 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 231 |
| Crush injury | adult | 1 g | IV/IO | not captured | standing | page 231 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 231 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5% gel | TD | not captured | standing | page 197 |
| Other | adult | 4 mL | NEB | not captured | standing | page 197 |
| Other | peds | 2.5% gel | TD | not captured | standing | page 197 |
| Other | peds | 4 mL | NEB | not captured | standing | page 197 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV | not captured | standing | page 61 |
| Sepsis | peds | 50 mg/kg | IV | not captured | standing | page 61 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 58 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 59 |
| Croup | adult | 16 mg | IV/IO/IM/PO | not captured | standing | page 163 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 163 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 1 mL/kg | IV/IO | not captured | standing | page 162 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 64 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 64 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | page 67 |
| Hyperactive delirium | adult | 4 mg | IV/IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 5 mg | IV/IM | not captured | standing | page 56 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 66 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 10 mg | IV/IO | not captured | standing | page 109 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 58 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 58 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 63 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 63 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 68 |
| Nausea / vomiting | adult | 1.25 mg | IV | not captured | standing | page 69 |
| RSI induction | adult | 1.25 mg | IV | not captured | standing | page 55 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 58 |
| Anaphylaxis | adult | 1 mL | IV/IO | not captured | standing | page 58 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | page 59 |
| Bradycardia | adult | 1 mL | IV/IO | not captured | standing | page 108 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 108 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 106 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 73 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 106 |
| CHF / pulmonary edema | adult | 2–20 mcg | IV/IO | not captured | standing | page 111 |
| Croup | peds | 3 mg | NEB | not captured | standing | page 163 |
| Neonatal resuscitation | peds | 0.01–0.03 mg/kg | IV/IO | not captured | standing | page 175 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 243 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 110 |
| Nausea / vomiting | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | adult | 25–50 mcg | IV/IM | not captured | standing | page 135 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | page 69 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IM | not captured | standing | page 135 |
| Post-intubation sedation | adult | 25–50 mcg | IV/IO | not captured | standing | page 56 |
Hydroxycobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 195 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 195 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 59 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 68 |
| Bradycardia | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 108 |
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 68 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 135 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 56 |
| Narrow-complex tachycardia | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 109 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IM | not captured | standing | page 43 |
| Severe pain | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 43 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mg/kg | IV | not captured | standing | page 251 |
| Other | adult | 20–40 mg | IO | not captured | standing | page 251 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM | not captured | standing | page 67 |
| Hyperactive delirium | adult | 4 mg | IV/IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 2–4 mg | IV/IM | not captured | standing | page 56 |
| Seizure | adult | 2 mg | IV/IO/IM | not captured | standing | page 56 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 56 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 45 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | page 45 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 253 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 45 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 41 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 58 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 58 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 59 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 59 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 109 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 67 |
| Bradycardia | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 108 |
| CHF / pulmonary edema | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 111 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 68 |
| Post-intubation sedation | adult | 5 mg | IV/IO/IM | not captured | standing | page 56 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 66 |
| Seizure | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 66 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 66 |
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 109 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 259 |
| Mild to moderate pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 135 |
| Mild to moderate pain | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 174 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5–2 mg | IV/IO/IM | not captured | standing | page 63 |
| Opioid overdose | adult | 2–4 mg | IN | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | page 63 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 110 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 111 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–12 mcg | IV/IO | not captured | standing | page 111 |
| Hypotension / shock | adult | 2–12 mcg | IV/IO | not captured | standing | page 60 |
| Post-ROSC care | adult | 2–12 mcg | IV/IO | not captured | standing | page 107 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 4 mg | IV | not captured | standing | page 110 |
| Nausea / vomiting | adult | 4 mg | IV/IO/PO | not captured | standing | page 69 |
| Nausea / vomiting | peds | 2 mg | IV/IO/PO | not captured | standing | page 69 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 135 |
| RSI induction | adult | 4 mg | IV/IO | not captured | standing | page 55 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 64 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 64 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1 g | IV/IO | not captured | standing | page 196 |
| Organophosphate poisoning | peds | 15 mg/kg | IV/IO | not captured | standing | page 196 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | page 204 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 100 mEq | IV/IO | not captured | standing | page 68 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 139 |
| Hyperkalemia | adult | 100 mEq | IV/IO | not captured | standing | page 139 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 63 |
| Other | adult | 2.5 mL | NEB | not captured | standing | page 198 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV/IO | not captured | standing | page 63 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 204 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 76 |